Contents
Editor’s Letter
Original Research
Social trust and regional variation in the adoption of biosimilars in Italy and Germany
US prescribers’ attitudes and perceptions about biosimilars
Review Article
Development of Ph. Eur. standards for therapeutic monoclonal antibodies: infliximab case study
Meeting Report
Key factors for successful uptake of biosimilars: Europe and the US